The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Legislators and medical policy advocates revealed the proposal at a press conference Wednesday at the capitol in Springfield.

The Police Scotland campaign ran from 1 December until 19 January. Community referrals for help with issues with substance use are on the rise in Guernsey, a charity says More than 3,000 people ...

The central drug regulatory authority of India has formed a panel to evaluate the efficacy of ... The Central Drugs Standards Control Organisation (CDSCO) — the apex regulatory agency — on January 10 ...

The International Council for Harmonisation (ICH)'s guideline entitled, ICH M13A: Bioequivalence for Immediate Release Solid Oral Dosage Forms is intended to provide recommendations on conducting ...

Laxxon’s microtablets offer unique advantages over traditional dosage forms: Enhanced Bioavailability: Overcomes challenges of poorly soluble APIs by increasing surface area and absorption. Controlled ...

"The $7.3 billion is the difference between what they are reimbursing themselves and what it is estimated to cost them to acquire the drug," an FTC spokesperson told reporters in a press briefing ...

Okubo, chief of the directorial staff, has been instructed to form a dedicated Task Force to ... as well as delays and bungling in the prosecution of a drug case, against 30 police officers.

This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property ...

Mounjaro (tirzepatide) is a brand-name drug prescribed to treat type 2 diabetes in adults. Mounjaro comes as a solution inside injection pens that you’ll administer weekly as a subcutaneous ...

Microsoft has created a new engineering organization aimed at accelerating AI infrastructure and software development within the company. According to Bloomberg, Jay Parikh, previously VP and ...

Since then, facilities have opened across Europe, North America and Australia, where they form one part of the overall response to drug harm. Globally, there are over 100 drug consumption ...